Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits

Diabetologia

Volumn 40, Issue 5, 1997, Pages 512-520

  Nordestgaard, B G ^a,c   Agerholm Larsen, B ^a   Stender, S ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Koege Hospital   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

atherosclerosis; C peptide; diabetes mellitus; hepatic lipase; hyperinsulinaemia; insulin; insulin antibodies; intermediate density lipoprotein; lipoprotein lipase; postprandial triglycerides

Indexed keywords

C PEPTIDE; CHOLESTEROL; INSULIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL DIET; CONTROLLED STUDY; FEMALE; HYPERINSULINEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; AORTA; ARTERIOSCLEROSIS; BLOOD GLUCOSE; C-PEPTIDE; CHOLESTEROL; CHOLESTEROL, DIETARY; DIET, ATHEROGENIC; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN ANTIBODIES; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, IDL; LIVER; PLACEBOS; PREDICTIVE VALUE OF TESTS; RABBITS; RECOMBINANT PROTEINS; TIME FACTORS; TRIGLYCERIDES;

EID: 0031002083     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050709     Document Type: Article

References (53)

1. Bierman EL (1992) Atherogenesis in diabetes. Arterioscler Thromb 12: 647-656
2. Stout RW (1994) The impact of insulin upon atherosclerosis. Horm Metab Res 26: 125-128
3. Jarrett RJ (1994) Why is insulin not a risk factor for coronary heart disease? Diabetologia 37: 945-947
4. Fontbonne A (1994) Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia 37: 953-955
5. Stern MP (1994) The insulin resistance syndrome: the controversy is dead, long live the controversy! Diabetologia 37: 956-958
6. Reaven GM, Laws A (1994) Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 37: 948-952
7. Reaven GM (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75: 473-486
8. Mahley RW, Rall SC (1995) Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, Inc. New York, pp 1953-1980
9. Krauss RM, Levy RI, Frederickson DS (1974) Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest 54: 1107-1124
10. Van Heek M, Zilversmit DB (1990) Postprandial lipemia and lipoprotein lipase in the rabbit are modified by olive and coconut oil. Arteriosclerosis 10: 421-429
11. Belfrage P, Vaughan M (1969) Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glyceride. J Lipid Res 10: 341-344
12. Gundersen HJG, Bendtsen TF, Korbo L et al. (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96: 379-394
13. Jaroß W, Honigmann G, Kunze D, Hildmann W, Trübsbach A (1984) Anleitungen für klinische laboratoriums-metoden. VEB Verlag Volk und Gesundheit, Berlin
14. Nielsen LB, Nordestgaard BG, Stender S, Kjeldsen K (1993) Aortic esterified cholesterol is not superior to total cholesterol as a measure of atherosclerosis severity in cholesterol-fed rabbits. Atherosclerosis 99: 133-136
15. Hansen BF, Mortensen A, Hansen BF, Ipsen P, Frandsen H, Nordestgaard BG (1994) Atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Evaluation of macroscopic, microscopic and biochemical methods and comparison of atherosclerosis variables. APMIS 102: 177-190
16. Jacobsson LS, Persson K, Aberg G, Andersson RGG, Karlberg BE, Olsson AG (1994) Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs. J Cardiovasc Pharmacol 24: 670-677
17. Norusis MJ and SPSS Inc. 6.0 (1993). SPSS for Windows. Base system's guide, release 6.0. SPSS Inc, Chicago, USA
18. Ryan BF, Joiner BL, Ryan TA Jr (1985) Minitab handbook, 2nd edn. Duxbury Press, Boston
19. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ (1988) Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 29: 469-479
20. Stout RW (1970) Development of vascular lesions in insulin-treated animals fed a normal diet. BMJ 3: 685-687
21. Falholt K, Alberti KGMM, Heding LG (1985) Aorta and muscle metabolism in pigs with peripheral hyperinsulinaemia. Diabetologia 28: 32-37
22. Falholt K, Cutfield R, Alejandro R, Heding L, Mintz D (1985) The effects of hyperinsulinemia on arterial wall and peripheral muscle metabolism in dogs. Metabolism 34: 1146-1149
23. Sato Y, Shiraishi S, Oshida Y, Ishiguro T, Sakamoto N (1989) Experimental atherosclerosis-like lesions induced by hyperinsulinism in Wistar rats. Diabetes 38: 91-96
24. Stary HC, Chandler AB, Glagov S et al. (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Arterioscler Thromb 14: 840-856
25. Nordestgaard BG, Zilversmit DB (1988) Hyperglycemia in normotriglyceridemic, hypercholesterolemic insulin-treated diabetic rabbits does not accelerate atherogenesis. Atherosclerosis 72: 37-47
26. Genuth S (1996) Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus. Ann Intern Med 124: 104-109
27. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329: 977-986
28. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J (1985) Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value over 9.5 year follow-up of the Helsinki Policemen Study population. Acta Med Scand 701 [Suppl]:38-52
29. Eschwege E, Richard JL, Thibult N et al. (1985) Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res 15 [Suppl]:41-46
30. Welborn TA, Wearne K (1979) Coronary heart disease and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2: 154-160
31. Zilversmit DB (1979) Atherogenesis: a postprandial phenomenon. Circulation 60: 473-485
32. Zilversmit DB (1995) Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem 41: 153-158
33. Nordestgaard BG, Lewis B (1991) Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain. Atherosclerosis 87: 39-46
34. Daley SJ, Herderick EE, Cornhill JF, Rogers KA (1994) Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 1: Differing lesion area and volume despite equal plasma cholesterol levels. Arterioscler Thromb 14: 95-104
35. Tatami R, Mabuchi H, Ueda K et al. (1981) Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 64: 1174-1184
36. Reardon MF, Nestel PJ, Craig IH, Harper RW (1985) Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 71: 881-888
37. Steiner G, Schwartz L, Shumak S, Poapst M (1987) The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 75: 124-130
38. Krauss RM, Lindgren FT, Williams PT et al. (1987) Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolemic men. Lancet II:62-66
39. Phillips NR, Waters D, Havel RJ (1993) Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88: 2762-2770
40. Nestel PJ, Fidge NH, Tan MH (1982) Increased lipoprotein-remnant formation in chronic renal failure. New Engl J Med 307: 329-333
41. Kasama T, Yoshino G, Iwatani I et al. (1987) Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics. Atherosclerosis 63: 263-266
42. Simons LA, Dwyer T, Simons J et al. (1987) Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis 65: 181-189
43. Simpson HS, Williamson CM, Olivecrona T et al. (1990) Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 85: 193-202
44. Groot PHE, van Stiphout WAHJ, Krauss XH et al. (1991) Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11: 653-662
45. Ryu JE, Howard G, Craven TE, Bond MG, Hagaman AP, Crouse JR (1992) Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 23: 823-828
46. Patsch JR, Miesenböck G, Hopferwieser T et al. (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12: 1336-1345
47. Uiterwaal CSPM, Grobbee DE, Witteman JCM et al. (1994) Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med 121: 576-583
48. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A (1994) Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106: 83-97
49. Shaikh M, Wootton R, Nordestgaard BG et al. (1991) Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans. Arterioscler Thromb 11: 569-577
50. Nordestgaard BG, Wootton R, Lewis B (1995) Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol 15: 534-542
51. Rapp JH, Lespine A, Hamilton RL et al. (1994) Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb 14: 1767-1774
52. Bradley WA, Gianturco SH (1994) Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations. J Intern Med 236 [Suppl]736: 33-39
53. Appleyard M, Hansen AT, Schnohr P, Jensen G, Nyboe J (1989) The Copenhagen City Heart Study, Østerbroundersøgelsen. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). Scand J Soc Med 170 [Suppl]41: 1-160